Horizon 3 Healthcare
Horizon 3 Healthcare, established in 2020 and based in Melbourne, Australia, specializes in investing in growth-stage healthcare companies that have demonstrated clinical validation and are generating revenue. The firm focuses on a diverse range of sectors within the healthcare industry, including biotechnology, medical devices, pharmaceuticals, digital health, diagnostics, medtech, and life sciences. By targeting established companies that are poised for further growth, Horizon 3 Healthcare aims to contribute to advancements in healthcare while achieving strong investment returns.
Cardiac Dimensions
Series E in 2025
Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.